Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing ...

The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s in vivo mRNA-encoded CAR T-cell program. In an interesting—if not somewhat ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice within hours. (Nanowerk Spotlight) Messenger RNA (mRNA) vaccines ...

Cancer patients who received mRNA COVID vaccines within 100 days of starting immunotherapy were twice as likely to be alive three years after treatment as those who never received a vaccine These ...

Please provide your email address to receive an email when new articles are posted on . Interferon lambda-encoding messenger RNA drug ETH47 was generally safe in healthy individuals. A phase 2a trial ...

Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune Fortifying RNAs (UNIFYRs™) as a new class of RNA therapeutics poised to transform ...

13:23 EDT Moderna (MRNA) down 4.2% after publishing results on mRNA-4359 plus pembrolizumab Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...